The Trillium Therapeutics brand, founded in 2004 (Canada), from 1125 sister brands and 17477 competing brands. The Trillium Therapeutics brand is owned by Pfizer Inc, a company listed in New York. The sector of Trillium Therapeutics is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Pfizer Inc
(Trillium Therapeutics)
over 5 years*
USD 18.24